AVIR Operating Income Growth
Atea Pharmaceuticals Inc · Operating Income Growth
AVIR Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-17.24%period ending
AVIR TTM Operating Income YoY % (24.49% → -17.24%)
Year-over-year change
High-resolution chart · PNG
AVIR operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -17.236% | |
| -17.0601% | |
| 6.2519% | |
| 17.715% | |
| 23.2585% | |
| 15.7038% | |
| -17.5363% | |
| -27.3094% | |
| -53.4621% | |
| -47.9492% | |
| -25.6502% | |
| -617.5419% | |
| -641.3776% | |
| -298.4011% | |
| -194.4167% | |
| -19.5867% | |
| -42.0113% | |
| 176.9159% | |
| 1,354.5422% | |
| 203.8873% | |
| 287.716% | |
| 245.3842% | |
| 24.4934% |